Hanson Wade

R&D

Partner Content

The Obesity Drug Development Summit has landed in Europe!

The Obesity Drug Development Summit Europe is your perfect platform to be in a prime position to be at the forefront of this movement.

R&D

Partner Content

8th Neuropsychiatric Drug Development Summit

The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum, capturing advancements across discovery...

R&D

Partner Content

7th TRP Europe | November 2025, Amsterdam | Agenda Released

With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, real momentum is building in the field.

Market Access

Partner Content

13th IMPACCT Real-World Evidence Summit

Recognized as the industry’s most established and trusted event for real-world evidence and evidence generation professionals

R&D

Partner Content

16th World ADC San Diego 2025

The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference

Market Access

Partner Content

EVERSANA expands commercialisation portfolio with OS Therapi...

EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic partnerships to support the US commercialisation of innovative therapies from O

The Obesity Drug Development Summit has landed in Europe!

8th Neuropsychiatric Drug Development Summit

7th TRP Europe | November 2025, Amsterdam | Agenda Released

13th IMPACCT Real-World Evidence Summit

16th World ADC San Diego 2025

EVERSANA expands commercialisation portfolio with OS Therapi...

LSX2026: On a therapeutic vision for ocular disease, with Al...

Using AI-driven synthetic personas to take your insights fur...

Hanson Wade

Editor's Picks